Cedilla Therapeutics
Biotechnology Research
245 First Street
6 employees
- Employees
- 6
- Contacts
- 1
- Emails
- 1
- Phones
- 1
Cedilla Therapeutics Overview
- Headquarters
- 245 First Street
- Website
- cedillatx.com
- Industry
- Biotechnology Research
- Employees
- 6
- Founded
- 2018
- Funding
- 25.0M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Cedilla Therapeutics
For 60 years, sequence and structure has been the primary lens to understand protein function. It’s now time to look beyond and leverage the orchestration of protein function within cells. Cedilla Therapeutics is bringing a new dimension to precision oncology. We have discovered new ways to selectively inhibit oncogenic drivers with small molecules that conditionally modulate proteins in their functional state. Our conditional inhibitors are unlocking critical and elusive cancer targets including TEAD and CDK2. We are a driven and patient-focused team.
Cedilla Therapeutics Contact Details
- People in AeroLeads
- 2
- With contact data
- 1
- Email contacts
- 1
- 50.0% coverage
- Phone contacts
- 1
- 50.0% coverage
Cedilla Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Alan D'andrea | Professor, Harvard Medical School | Boston, Massachusetts, United States |
Email
Phone
|
| Nayan Chavda | Manager at Cedilla Therapeutics | Ahmedabad, Gujarat, India |
View
|
Employees by Management Level
Individual contributor
4 profiles
Manager
1 profile
Compare Similar Companies to Cedilla Therapeutics
Agios Pharmaceuticals
Pharmaceutical Manufacturing
Beam Therapeutics
Biotechnology Research
Tessera Therapeutics
Biotechnology Research
Relay Therapeutics
Biotechnology Research
Tango Therapeutics
Biotechnology Research
Nimbus Therapeutics
Biotechnology Research
MOMA Therapeutics
Biotechnology Research
Magnet Biomedicine
Biotechnology Research
Casma Therapeutics
Biotechnology Research
Celsius Therapeutics
Biotechnology Research